Bruno Larvol, Founder and CEO of the Healthcare Data Company, Larvol - Episode 19
Update: 2020-06-22
Description
We have seen tremendous advances in sequencing technology. And the cost to sequence is going to zero, according to Moore's Law. More and more genes and gene sets are being correlated with clinical outcome and response to therapy.
Is bioinformatics intelligence the missing link to realizing the promise of precision medicine?
Will a company emerge as the Google or Amazon of cancer informatics?
Our guest is Bruno Larvol, of the eponymous healthcare data company, Larvol.
Is bioinformatics intelligence the missing link to realizing the promise of precision medicine?
Will a company emerge as the Google or Amazon of cancer informatics?
Our guest is Bruno Larvol, of the eponymous healthcare data company, Larvol.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
